Lee:Research: Revision history

9 December 2020

• curprev 11:1911:19, 9 December 2020‎ Wooin Lee talk contribs‎ 7,258 bytes +30‎ →‎I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes

12 June 2020

• curprev 23:3023:30, 12 June 2020‎ Wooin Lee talk contribs‎ 7,228 bytes +59‎ →‎I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes
• curprev 23:2823:28, 12 June 2020‎ Wooin Lee talk contribs‎ 7,169 bytes −1,337‎ →‎I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes
• curprev 23:2423:24, 12 June 2020‎ Wooin Lee talk contribs‎ 8,506 bytes −1,981‎ →‎III. Clinical Pharmacokinetics, Pharmacogenomics & Pharmacometrics
• curprev 23:1923:19, 12 June 2020‎ Wooin Lee talk contribs‎ 10,487 bytes +1‎ →‎I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes
• curprev 23:1923:19, 12 June 2020‎ Wooin Lee talk contribs‎ 10,486 bytes −13‎ →‎II. Development of novel proteasome inhibitor drugs and delivery strategies to improve anticancer efficacy and expand therapeutic utilities
• curprev 23:1723:17, 12 June 2020‎ Wooin Lee talk contribs‎ 10,499 bytes −1,304‎ →‎II. Development of novel proteasome inhibitor drugs and delivery strategies to improve anticancer efficacy and expand therapeutic utilities

14 June 2019

• curprev 03:0003:00, 14 June 2019‎ Wooin Lee talk contribs‎ 11,803 bytes −1‎ →‎II. Development of novel proteasome inhibitor drugs and delivery strategies to improve anticancer efficacy and expand therapeutic utilities

11 April 2019

• curprev 09:2409:24, 11 April 2019‎ Wooin Lee talk contribs‎ 11,804 bytes +300‎ →‎III. Clinical Pharmacokinetics, Pharmacogenomics & Pharmacometrics
• curprev 09:2309:23, 11 April 2019‎ Wooin Lee talk contribs‎ 11,504 bytes +201‎ →‎II. Development of novel proteasome inhibitor drugs and delivery strategies to improve anticancer efficacy and expand therapeutic utilities

18 November 2018

• curprev 03:3903:39, 18 November 2018‎ Wooin Lee talk contribs‎ 11,303 bytes +286‎ →‎III. Clinical Pharmacokinetics, Pharmacogenomics & Pharmacometrics

2 June 2018

• curprev 06:3906:39, 2 June 2018‎ Wooin Lee talk contribs‎ 11,017 bytes +7‎ →‎III. Clinical Pharmacokinetics, Pharmacogenomics & Pharmacometrics
• curprev 06:3706:37, 2 June 2018‎ Wooin Lee talk contribs‎ 11,010 bytes +134‎ →‎II. Development of novel proteasome inhibitor drugs and delivery strategies to improve anticancer efficacy and expand therapeutic utilities
• curprev 06:3606:36, 2 June 2018‎ Wooin Lee talk contribs‎ 10,876 bytes +23‎ No edit summary

1 March 2018

• curprev 09:0309:03, 1 March 2018‎ Wooin Lee talk contribs‎ 10,853 bytes +590‎ →‎III. Clinical Pharmacokinetics, Pharmacogenomics & Pharmacometrics

21 September 2017

• curprev 17:2117:21, 21 September 2017‎ Wooin Lee talk contribs‎ 10,263 bytes +86‎ No edit summary
• curprev 17:2017:20, 21 September 2017‎ Wooin Lee talk contribs‎ 10,177 bytes +111‎ No edit summary
• curprev 17:1817:18, 21 September 2017‎ Wooin Lee talk contribs‎ 10,066 bytes +47‎ →‎I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes
• curprev 17:1817:18, 21 September 2017‎ Wooin Lee talk contribs‎ 10,019 bytes −91‎ No edit summary
• curprev 17:1617:16, 21 September 2017‎ Wooin Lee talk contribs‎ 10,110 bytes +166‎ →‎I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes
• curprev 09:2209:22, 21 September 2017‎ Wooin Lee talk contribs‎ 9,944 bytes −8‎ No edit summary
• curprev 09:2109:21, 21 September 2017‎ Wooin Lee talk contribs‎ 9,952 bytes +212‎ No edit summary
• curprev 09:1609:16, 21 September 2017‎ Wooin Lee talk contribs‎ 9,740 bytes +19‎ →‎II. Development of novel proteasome inhibitor drugs and delivery strategies to improve anticancer efficacy and expand therapeutic utilities
• curprev 09:1009:10, 21 September 2017‎ Wooin Lee talk contribs‎ 9,721 bytes +22‎ →‎I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes
• curprev 09:0709:07, 21 September 2017‎ Wooin Lee talk contribs‎ 9,699 bytes +147‎ →‎III. Clinical Pharmacokinetics and Pharmacogenomics
• curprev 09:0209:02, 21 September 2017‎ Wooin Lee talk contribs‎ 9,552 bytes +910‎ →‎III. Cancer Pharmacogenomics
• curprev 08:5308:53, 21 September 2017‎ Wooin Lee talk contribs‎ 8,642 bytes +517‎ →‎II. Development of novel proteasome inhibitor drugs and delivery strategies to improve anticancer efficacy and expand therapeutic utilities
• curprev 08:5008:50, 21 September 2017‎ Wooin Lee talk contribs‎ 8,125 bytes +1,061‎ →‎II. Development of novel proteasome inhibitor drugs and delivery strategies to improve anticancer efficacy and expand therapeutic utilities
• curprev 08:2908:29, 21 September 2017‎ Wooin Lee talk contribs‎ 7,064 bytes +269‎ →‎I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes
• curprev 08:2808:28, 21 September 2017‎ Wooin Lee talk contribs‎ 6,795 bytes −5‎ →‎I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes
• curprev 08:2808:28, 21 September 2017‎ Wooin Lee talk contribs‎ 6,800 bytes +1,206‎ →‎I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes
• curprev 04:4004:40, 21 September 2017‎ Wooin Lee talk contribs‎ 5,594 bytes +1,436‎ No edit summary

20 June 2014

• curprev 10:4110:41, 20 June 2014‎ Wooin Lee talk contribs‎ 4,158 bytes +1,299‎ No edit summary

17 June 2014

• curprev 12:5012:50, 17 June 2014‎ Wooin Lee talk contribs‎ 2,859 bytes +3‎ No edit summary
• curprev 12:4212:42, 17 June 2014‎ Wooin Lee talk contribs‎ 2,856 bytes +147‎ No edit summary

2 August 2010

• curprev 06:3506:35, 2 August 2010‎ Wooin Lee talk contribs‎ 2,709 bytes +702‎ →‎III. Immunoproteasome as a Novel Anticancer Target

1 August 2010

• curprev 20:5520:55, 1 August 2010‎ Wooin Lee talk contribs‎ 2,007 bytes +58‎ No edit summary

22 July 2010

• curprev 08:3308:33, 22 July 2010‎ Wooin Lee talk contribs‎ 1,949 bytes −1‎ →‎I. Roles of Drug Transporters in Cancer Therapy
• curprev 08:3008:30, 22 July 2010‎ Wooin Lee talk contribs‎ 1,950 bytes +42‎ No edit summary

19 July 2010

• curprev 18:4918:49, 19 July 2010‎ Wooin Lee talk contribs‎ 1,908 bytes +1,056‎ →‎Roles of Drug Transporters in Cancer Therapy
• curprev 18:4818:48, 19 July 2010‎ Wooin Lee talk contribs‎ 852 bytes −460‎ No edit summary
• curprev 18:2118:21, 19 July 2010‎ Wooin Lee talk contribs‎ 1,312 bytes +1,179‎ No edit summary
• curprev 17:5917:59, 19 July 2010‎ Wooin Lee talk contribs‎ 133 bytes −1,414‎ Replacing page with '{{Lee_lab}} {|cellspacing="5" cellpadding="10" style="background:#3674C2; width: 1000px;" |-valign="top" |style="background:#ffffff"|'

16 June 2009

• curprev 01:3401:34, 16 June 2009‎ Wooin Lee talk contribs‎ 1,547 bytes +1,547‎ No edit summary

15 June 2009

• curprev 23:2923:29, 15 June 2009‎ Wooin Lee talk contribs‎ empty −1,964‎ Removing all content from page
• curprev 00:2200:22, 15 June 2009‎ Wooin Lee talk contribs‎ 1,964 bytes +1,964‎ New page: ==Research Interests== Dr. Lee's research interests focus on understanding the genetic and molecular bases for interindividual variations with a particular emphasis on drug metabolism and...